We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Guidance for the pharmaceutical industry on how to apply to vary a veterinary Marketing Authorisation (MA) or Homeopathic Remedy.
Apply for changes to your marketing authorisation, including minor variations type IA and IB, major variations type II and extensions.
How the MHRA processes variations to Marketing Authorisations (MAs)
Check what UIDs you need for your tobacco products and the specifications they need to meet.
How to get a parallel import licence for your medicine in the UK, including pharmacovigilance requirements and submitting your application.
How to use a quasi-experimental study to evaluate your digital health product.
The New Variant Assessment Platform (NVAP) is an offer of UK capacity and expertise to detect and assess new variants of SARS-CoV-2 around the world.
Forms to make a variation to a manufacturer's licence.
Information to support your recovery after COVID-19.
Guidance for manufacturers, importers and distributors.
Guidance for the pharmaceutical industry on who can be a Marketing Authorisation Holder, named distributor or local representative and how to make changes to these.
Protocols and procedures for testing the distinctiveness, uniformity and stability (DUS) of certain agricultural and vegetable plants.
Information on variants of the SARS-CoV-2 virus.
Apply to manufacture Extemporaneous preparations, Autogenous vaccines, authorisations for Equine Stem Cell Centre (ESCCA) or Non-Food Animal Blood Bank (NFABBA).
A set of principles for understanding the impact of new variants on antiviral drugs and monoclonal antibodies
Information and guidance for variations in names.
Changing an inheritance after death (a 'variation') and how it can affect amounts of Inheritance and Capital Gains tax due
How to apply for a clinical trial including eligibility, phases, model IMPDs, costs and how to make changes to your application.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.